NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including the Maxcess integrated split-blade retractor system, which enables less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery. The company also offers specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone, as well as fixation systems that facilitate the preservation and restoration of patient alignment.
Additionally, NuVasive provides cervical total disc replacement technology for cervical spinal fusion surgery and neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, along with its intraoperative neuromonitoring services and support. The Pulse platform is another offering, serving as a software ecosystem that integrates multiple hardware technologies into a single, condensed footprint in the operating room.
The company also offers expandable growing rod implant systems for the treatment of early-onset scoliosis and various biologics that are used to aid in the spinal fusion or bone healing process. Furthermore, it provides Precice, an intramedullary device that utilizes MAGEC technology to non-invasively lengthen the femur and tibia, as well as onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries.
NuVasive, Inc. sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. The company was incorporated in 1997 and is headquartered in San Diego, California. As of September 1, 2023, NuVasive, Inc. operates as a subsidiary of Globus Medical, Inc.
